Thomas Jefferson University

Jeffrey Peters

TitleAdjunct Faculty
InstitutionPhiladelphia University
DepartmentArchitecture
Address3243 School House Lane
Philadelphia PA 19144
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yokoyama S, Koo I, Aibara D, Tian Y, Murray IA, Collins SL, Coslo DM, Kono M, Peters JM, Proia RL, Gonzalez FJ, Perdew GH, Patterson AD. Sphingosine Kinase 2 Regulates Aryl Hydrocarbon Receptor Nuclear Translocation and Target Gene Activation. Adv Sci (Weinh). 2024 Aug 29; e2400794. PMID: 39207053.
      Citations:    
    2. Zhu B, Zhu X, Borland MG, Ralph DH, Chiaro CR, Krausz KW, Ntambi JM, Glick AB, Patterson AD, Perdew GH, Gonzalez FJ, Peters JM. Activation of Peroxisome Proliferator-Activated Receptor-?/d (PPAR?/d) in Keratinocytes by Endogenous Fatty Acids. Biomolecules. 2024 May 21; 14(6). PMID: 38927010.
      Citations:    
    3. Zhu X, Liu Q, Patterson AD, Sharma AK, Amin SG, Cohen SM, Gonzalez FJ, Peters JM. Accumulation of Linoleic Acid by Altered Peroxisome Proliferator-Activated Receptor-a Signaling Is Associated with Age-Dependent Hepatocarcinogenesis in Ppara Transgenic Mice. Metabolites. 2023 Aug 10; 13(8). PMID: 37623879.
      Citations:    
    4. States JC, Peters JM. 2020-2021 Toxicological Sciences Paper of the Year. Toxicol Sci. 2022 03 28; 186(2):177-178. PMID: 35348797.
      Citations:    
    5. Su S, Billy LJ, Chang S, Gonzalez FJ, Patterson AD, Peters JM. The role of mouse and human peroxisome proliferator-activated receptor-a in modulating the hepatic effects of perfluorooctane sulfonate in mice. Toxicology. 2022 01 15; 465:153056. PMID: 34861291.
      Citations:    
    6. Foreman JE, Koga T, Kosyk O, Kang BH, Zhu X, Cohen SM, Billy LJ, Sharma AK, Amin S, Gonzalez FJ, Rusyn I, Peters JM. Diminished Hepatocarcinogenesis by a Potent, High-Affinity Human PPARa Agonist in PPARA-Humanized Mice. Toxicol Sci. 2021 08 30; 183(1):70-80. PMID: 34081128.
      Citations:    
    7. Foreman JE, Koga T, Kosyk O, Kang BH, Zhu X, Cohen SM, Billy LJ, Sharma AK, Amin S, Gonzalez FJ, Rusyn I, Peters JM. Species Differences between Mouse and Human PPARa in Modulating the Hepatocarcinogenic Effects of Perinatal Exposure to a High-Affinity Human PPARa Agonist in Mice. Toxicol Sci. 2021 08 30; 183(1):81-92. PMID: 34081146.
      Citations:    
    8. Peters JM. Moving Forward With ToxSci. Toxicol Sci. 2020 02 01; 173(2):227-228. PMID: 31990976.
      Citations:    
    9. Zhang L, Rimal B, Nichols RG, Tian Y, Smith PB, Hatzakis E, Chang SC, Butenhoff JL, Peters JM, Patterson AD. Perfluorooctane sulfonate alters gut microbiota-host metabolic homeostasis in mice. Toxicology. 2020 02 15; 431:152365. PMID: 31926186.
      Citations:    
    10. Peters JM. Change is Good: What is New for ToxSci? Toxicol Sci. 2020 01 01; 173(1):1-2. PMID: 31904856.
      Citations:    
    11. Peters JM, Walter V, Patterson AD, Gonzalez FJ. Unraveling the role of peroxisome proliferator-activated receptor-?/d (PPAR?/d) expression in colon carcinogenesis. NPJ Precis Oncol. 2019; 3:26. PMID: 31602402.
      Citations:    
    12. Peters JM. Continuing a Legacy: Adapting to Ensure the Bright Future of ToxSci. Toxicol Sci. 2019 07 01; 170(1):1-2. PMID: 31237653.
      Citations:    
    13. Nichols RG, Peters JM, Patterson AD. Interplay Between the Host, the Human Microbiome, and Drug Metabolism. Hum Genomics. 2019 06 11; 13(1):27. PMID: 31186074.
      Citations:    
    14. Peters JM, Kim DJ, Bility MT, Borland MG, Zhu B, Gonzalez FJ. Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-?/d in skin cancer. Mol Carcinog. 2019 09; 58(9):1612-1622. PMID: 31062422.
      Citations:    
    15. Peters JM, Gonzalez FJ. The Evolution of Carcinogenesis. Toxicol Sci. 2018 10 01; 165(2):272-276. PMID: 30629266.
      Citations:    
    16. Patterson AD, Gonzalez FJ, Perdew GH, Peters JM. Molecular Regulation of Carcinogenesis: Friend and Foe. Toxicol Sci. 2018 10 01; 165(2):277-283. PMID: 30053205.
      Citations:    
    17. Borland MG, Kehres EM, Lee C, Wagner AL, Shannon BE, Albrecht PP, Zhu B, Gonzalez FJ, Peters JM. Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells. Toxicology. 2018 07 01; 404-405:25-32. PMID: 29729928.
      Citations:    
    18. Borland MG, Yao PL, Kehres EM, Lee C, Pritzlaff AM, Ola E, Wagner AL, Shannon BE, Albrecht PP, Zhu B, Kang BH, Robertson GP, Gonzalez FJ, Peters JM. Editor's Highlight: PPAR?/d and PPAR? Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis. Toxicol Sci. 2017 10 01; 159(2):436-448. PMID: 28962521.
      Citations:    
    19. Peters JM. Flipping a citrate switch on liver cancer cells. J Biol Chem. 2017 08 18; 292(33):13902-13903. PMID: 28821606.
      Citations:    
    20. Allen JN, Dey A, Nissly R, Fraser J, Yu S, Balandaram G, Peters JM, Hankey-Giblin PA. Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation. J Vis Exp. 2017 04 03; (122). PMID: 28447981.
      Citations:    
    21. Yao PL, Morales JL, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-?/d modulates mast cell phenotype. Immunology. 2017 04; 150(4):456-467. PMID: 27935639.
      Citations:    
    22. Yao PL, Chen L, Dobrzanski TP, Zhu B, Kang BH, M?ller R, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-?/d inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation. Mol Carcinog. 2017 05; 56(5):1472-1483. PMID: 27996177.
      Citations:    
    23. Nichols RG, Hume NE, Smith PB, Peters JM, Patterson AD. Omics Approaches To Probe Microbiota and Drug Metabolism Interactions. Chem Res Toxicol. 2016 12 19; 29(12):1987-1997. PMID: 27782392.
      Citations:    
    24. Koga T, Yao PL, Goudarzi M, Murray IA, Balandaram G, Gonzalez FJ, Perdew GH, Fornace AJ, Peters JM. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-?/d Modulation of SP1 Promoter Occupancy. J Biol Chem. 2016 Nov 25; 291(48):25255-25263. PMID: 27765815.
      Citations:    
    25. Zhang L, Krishnan P, Ehresman DJ, Smith PB, Dutta M, Bagley BD, Chang SC, Butenhoff JL, Patterson AD, Peters JM. Editor's Highlight: Perfluorooctane Sulfonate-Choline Ion Pair Formation: A Potential Mechanism Modulating Hepatic Steatosis and Oxidative Stress in Mice. Toxicol Sci. 2016 09; 153(1):186-97. PMID: 27413108.
      Citations:    
    26. Balandaram G, Kramer LR, Kang BH, Murray IA, Perdew GH, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-?/d suppresses liver tumorigenesis in hepatitis B transgenic mice. Toxicology. 2016 07 01; 363-364:1-9. PMID: 27427494.
      Citations:    
    27. Yu S, Allen JN, Dey A, Zhang L, Balandaram G, Kennett MJ, Xia M, Xiong N, Peters JM, Patterson A, Hankey-Giblin PA. The Ron Receptor Tyrosine Kinase Regulates Macrophage Heterogeneity and Plays a Protective Role in Diet-Induced Obesity, Atherosclerosis, and Hepatosteatosis. J Immunol. 2016 07 01; 197(1):256-65. PMID: 27233965.
      Citations:    
    28. Yao PL, Chen LP, Dobrzanski TP, Phillips DA, Zhu B, Kang BH, Gonzalez FJ, Peters JM. Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-?/d- and retinoic acid receptor-dependent mechanisms. Oncotarget. 2015 Nov 03; 6(34):36319-37. PMID: 26431381.
      Citations:    
    29. Peters JM, Gonzalez FJ, M?ller R. Establishing the Role of PPAR?/d in Carcinogenesis. Trends Endocrinol Metab. 2015 Nov; 26(11):595-607. PMID: 26490384.
      Citations:    
    30. Yao PL, Chen L, Hess RA, M?ller R, Gonzalez FJ, Peters JM. Peroxisome Proliferator-activated Receptor-D (PPARD) Coordinates Mouse Spermatogenesis by Modulating Extracellular Signal-regulated Kinase (ERK)-dependent Signaling. J Biol Chem. 2015 Sep 18; 290(38):23416-31. PMID: 26242735.
      Citations:    
    31. Peters JM, Yao PL, Gonzalez FJ. Targeting Peroxisome Proliferator-Activated Receptor-?/d (PPAR?/d) for Cancer Chemoprevention. Curr Pharmacol Rep. 2015; 1(2):121-128. PMID: 26000234.
      Citations:    
    32. Yao PL, Ehresman DJ, Rae JM, Chang SC, Frame SR, Butenhoff JL, Kennedy GL, Peters JM. Comparative in vivo and in vitro analysis of possible estrogenic effects of perfluorooctanoic acid. Toxicology. 2014 Dec 04; 326:62-73. PMID: 25456267.
      Citations:    
    33. Zhu B, Ferry CH, Markell LK, Blazanin N, Glick AB, Gonzalez FJ, Peters JM. The nuclear receptor peroxisome proliferator-activated receptor-?/d (PPAR?/d) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress. J Biol Chem. 2014 Jul 18; 289(29):20102-19. PMID: 24898257.
      Citations:    
    34. Borland MG, Krishnan P, Lee C, Albrecht PP, Shan W, Bility MT, Marcus CB, Lin JM, Amin S, Gonzalez FJ, Perdew GH, Peters JM. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor ?/d (PPAR?/d) in keratinocytes. Carcinogenesis. 2014 Jul; 35(7):1602-12. PMID: 24639079.
      Citations:    
    35. Yao PL, Morales JL, Zhu B, Kang BH, Gonzalez FJ, Peters JM. Activation of peroxisome proliferator-activated receptor-?/d (PPAR-?/d) inhibits human breast cancer cell line tumorigenicity. Mol Cancer Ther. 2014 Apr; 13(4):1008-17. PMID: 24464939.
      Citations:    
    36. Yao PL, Gonzalez FJ, Peters JM. Targeting estrogen receptor-? for the prevention of nonmelanoma skin cancer. Cancer Prev Res (Phila). 2014 Feb; 7(2):182-5. PMID: 24464730.
      Citations:    
    37. Lahoti TS, Hughes JM, Kusnadi A, John K, Zhu B, Murray IA, Gowda K, Peters JM, Amin SG, Perdew GH. Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Pharmacol Exp Ther. 2014 Feb; 348(2):236-45. PMID: 24309559.
      Citations:    
    38. Montanez JE, Peters JM, Correll JB, Gonzalez FJ, Patterson AD. Metabolomics: an essential tool to understand the function of peroxisome proliferator-activated receptor alpha. Toxicol Pathol. 2013 Feb; 41(2):410-8. PMID: 23197196.
      Citations:    
    39. Khozoie C, Borland MG, Zhu B, Baek S, John S, Hager GL, Shah YM, Gonzalez FJ, Peters JM. Analysis of the peroxisome proliferator-activated receptor-?/d (PPAR?/d) cistrome reveals novel co-regulatory role of ATF4. BMC Genomics. 2012 Nov 24; 13:665. PMID: 23176727.
      Citations:    
    40. Albrecht PP, Torsell NE, Krishnan P, Ehresman DJ, Frame SR, Chang SC, Butenhoff JL, Kennedy GL, Gonzalez FJ, Peters JM. A species difference in the peroxisome proliferator-activated receptor a-dependent response to the developmental effects of perfluorooctanoic acid. Toxicol Sci. 2013 Feb; 131(2):568-82. PMID: 23143925.
      Citations:    
    41. Zhu B, Khozoie C, Bility MT, Ferry CH, Blazanin N, Glick AB, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor ?/d cross talks with E2F and attenuates mitosis in HRAS-expressing cells. Mol Cell Biol. 2012 Jun; 32(11):2065-82. PMID: 22473992.
      Citations:    
    42. Peters JM, Shah YM, Gonzalez FJ. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer. 2012 Feb 09; 12(3):181-95. PMID: 22318237.
      Citations:    
    43. Peters JM, Foreman JE, Gonzalez FJ. Dissecting the role of peroxisome proliferator-activated receptor-?/d (PPAR?/d) in colon, breast, and lung carcinogenesis. Cancer Metastasis Rev. 2011 Dec; 30(3-4):619-40. PMID: 22037942.
      Citations:    
    44. Peters JM, Morales JL, Gonzalez FJ. Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-?/d (PPAR?/d). Drug Discov Today Dis Mech. 2011; 8(3-4):e85-e93. PMID: 22611424.
      Citations:    
    45. Peters JM, Gonzalez FJ. Why toxic equivalency factors are not suitable for perfluoroalkyl chemicals. Chem Res Toxicol. 2011 Oct 17; 24(10):1601-9. PMID: 21913657.
      Citations:    
    46. Patterson AD, Peters JM. PPAR action in insulin resistance unraveled by metabolomics: potential clinical implications. Genome Med. 2011 Aug 23; 3(8):54. PMID: 21861850.
      Citations:    
    47. Borland MG, Khozoie C, Albrecht PP, Zhu B, Lee C, Lahoti TS, Gonzalez FJ, Peters JM. Stable over-expression of PPAR?/d and PPAR? to examine receptor signaling in human HaCaT keratinocytes. Cell Signal. 2011 Dec; 23(12):2039-50. PMID: 21843636.
      Citations:    
    48. Foreman JE, Chang WC, Palkar PS, Zhu B, Borland MG, Williams JL, Kramer LR, Clapper ML, Gonzalez FJ, Peters JM. Functional characterization of peroxisome proliferator-activated receptor-?/d expression in colon cancer. Mol Carcinog. 2011 Nov; 50(11):884-900. PMID: 21400612.
      Citations:    
    49. Zhu B, Bai R, Kennett MJ, Kang BH, Gonzalez FJ, Peters JM. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2. Mol Cancer Ther. 2010 Dec; 9(12):3267-77. PMID: 21159610.
      Citations:    
    50. Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci. 2011 Mar; 120 Suppl 1:S49-75. PMID: 21059794.
      Citations:    
    51. Palkar PS, Anderson CR, Ferry CH, Gonzalez FJ, Peters JM. Effect of prenatal peroxisome proliferator-activated receptor alpha (PPARalpha) agonism on postnatal development. Toxicology. 2010 Sep 30; 276(1):79-84. PMID: 20637823.
      Citations:    
    52. Palkar PS, Borland MG, Naruhn S, Ferry CH, Lee C, Sk UH, Sharma AK, Amin S, Murray IA, Anderson CR, Perdew GH, Gonzalez FJ, M?ller R, Peters JM. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787. Mol Pharmacol. 2010 Sep; 78(3):419-30. PMID: 20516370.
      Citations:    
    53. Sharma AK, Sk UH, He P, Peters JM, Amin S. Synthesis of isosteric selenium analog of the PPARbeta/delta agonist GW501516 and comparison of biological activity. Bioorg Med Chem Lett. 2010 Jul 15; 20(14):4050-2. PMID: 20542425.
      Citations:    
    54. Foreman JE, Sorg JM, McGinnis KS, Rigas B, Williams JL, Clapper ML, Gonzalez FJ, Peters JM. Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs. Mol Carcinog. 2009 Oct; 48(10):942-52. PMID: 19415698.
      Citations:    
    55. Bility MT, Zhu B, Kang BH, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis. Toxicol Sci. 2010 Jan; 113(1):27-36. PMID: 19748995.
      Citations:    
    56. Foreman JE, Sharma AK, Amin S, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line. Cancer Lett. 2010 Feb 28; 288(2):219-25. PMID: 19660859.
      Citations:    
    57. Peters JM, Gonzalez FJ. Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer. Biochim Biophys Acta. 2009 Dec; 1796(2):230-41. PMID: 19505534.
      Citations:    
    58. Foreman JE, Chang SC, Ehresman DJ, Butenhoff JL, Anderson CR, Palkar PS, Kang BH, Gonzalez FJ, Peters JM. Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-alpha. Toxicol Sci. 2009 Jul; 110(1):204-11. PMID: 19359353.
      Citations:    
    59. Gopinathan L, Hannon DB, Peters JM, Vanden Heuvel JP. Regulation of peroxisome proliferator-activated receptor-alpha by MDM2. Toxicol Sci. 2009 Mar; 108(1):48-58. PMID: 19103650.
      Citations:    
    60. He P, Borland MG, Zhu B, Sharma AK, Amin S, El-Bayoumy K, Gonzalez FJ, Peters JM. Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines. Toxicology. 2008 Dec 05; 254(1-2):112-7. PMID: 18950674.
      Citations:    
    61. Bility MT, Devlin-Durante MK, Blazanin N, Glick AB, Ward JM, Kang BH, Kennett MJ, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis. Carcinogenesis. 2008 Dec; 29(12):2406-14. PMID: 18799709.
      Citations:    
    62. Borland MG, Foreman JE, Girroir EE, Zolfaghari R, Sharma AK, Amin S, Gonzalez FJ, Ross AC, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes. Mol Pharmacol. 2008 Nov; 74(5):1429-42. PMID: 18687807.
      Citations:    
    63. Peters JM, Hollingshead HE, Gonzalez FJ. Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease. Clin Sci (Lond). 2008 Aug; 115(4):107-27. PMID: 18616431.
      Citations:    
    64. Shan W, Palkar PS, Murray IA, McDevitt EI, Kennett MJ, Kang BH, Isom HC, Perdew GH, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression. Toxicol Sci. 2008 Oct; 105(2):418-28. PMID: 18622026.
      Citations:    
    65. Girroir EE, Hollingshead HE, He P, Zhu B, Perdew GH, Peters JM. Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice. Biochem Biophys Res Commun. 2008 Jul 04; 371(3):456-61. PMID: 18442472.
      Citations:    
    66. Shan W, Nicol CJ, Ito S, Bility MT, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice. Hepatology. 2008 Jan; 47(1):225-35. PMID: 18038451.
      Citations:    
    67. Girroir EE, Hollingshead HE, Billin AN, Willson TM, Robertson GP, Sharma AK, Amin S, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicology. 2008 Jan 14; 243(1-2):236-43. PMID: 18054822.
      Citations:    
    68. Hollingshead HE, Borland MG, Billin AN, Willson TM, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis. 2008 Jan; 29(1):169-76. PMID: 17893232.
      Citations:    
    69. Hollingshead HE, Killins RL, Borland MG, Girroir EE, Billin AN, Willson TM, Sharma AK, Amin S, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines. Carcinogenesis. 2007 Dec; 28(12):2641-9. PMID: 17693664.
      Citations:    
    70. Hollingshead HE, Morimura K, Adachi M, Kennett MJ, Billin AN, Willson TM, Gonzalez FJ, Peters JM. PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism. Dig Dis Sci. 2007 Nov; 52(11):2912-9. PMID: 17404849.
      Citations:    
    71. Coleman JD, Prabhu KS, Thompson JT, Reddy PS, Peters JM, Peterson BR, Reddy CC, Vanden Heuvel JP. The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). Free Radic Biol Med. 2007 Apr 15; 42(8):1155-64. PMID: 17382197.
      Citations:    
    72. Burdick AD, Bility MT, Girroir EE, Billin AN, Willson TM, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes. Cell Signal. 2007 Jun; 19(6):1163-71. PMID: 17254750.
      Citations:    
    73. Marin HE, Peraza MA, Billin AN, Willson TM, Ward JM, Kennett MJ, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. Cancer Res. 2006 Apr 15; 66(8):4394-401. PMID: 16618765.
      Citations:    
    74. Kim DJ, Prabhu KS, Gonzalez FJ, Peters JM. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). Carcinogenesis. 2006 May; 27(5):1105-12. PMID: 16418176.
      Citations:    
    75. Peraza MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci. 2006 Apr; 90(2):269-95. PMID: 16322072.
      Citations:    
    76. Murray IA, Reen RK, Leathery N, Ramadoss P, Bonati L, Gonzalez FJ, Peters JM, Perdew GH. Evidence that ligand binding is a key determinant of Ah receptor-mediated transcriptional activity. Arch Biochem Biophys. 2005 Oct 01; 442(1):59-71. PMID: 16137638.
      Citations:    
    77. Patel RD, Kim DJ, Peters JM, Perdew GH. The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin. Toxicol Sci. 2006 Jan; 89(1):75-82. PMID: 16192470.
      Citations:    
    78. Burdick AD, Kim DJ, Peraza MA, Gonzalez FJ, Peters JM. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. Cell Signal. 2006 Jan; 18(1):9-20. PMID: 16109478.
      Citations:    
    79. Peters JM, Cheung C, Gonzalez FJ. Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand? J Mol Med (Berl). 2005 Oct; 83(10):774-85. PMID: 15976920.
      Citations:    
    80. Kim DJ, Murray IA, Burns AM, Gonzalez FJ, Perdew GH, Peters JM. Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem. 2005 Mar 11; 280(10):9519-27. PMID: 15632134.
      Citations:    
    81. Peters JM, Kato S, Gonzalez FJ. The United States-Japan workshop on: The role of nuclear receptors in carcinogenesis. Mol Carcinog. 2004 Oct; 41(2):77-84. PMID: 15378646.
      Citations:    
    82. Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis. 2005 Jan; 26(1):219-27. PMID: 15447978.
      Citations:    
    83. Bility MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, Peters JM. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol Sci. 2004 Nov; 82(1):170-82. PMID: 15310864.
      Citations:    
    84. Harman FS, Nicol CJ, Marin HE, Ward JM, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. Nat Med. 2004 May; 10(5):481-3. PMID: 15048110.
      Citations:    
    85. Kim DJ, Akiyama TE, Harman FS, Burns AM, Shan W, Ward JM, Kennett MJ, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis. J Biol Chem. 2004 May 28; 279(22):23719-27. PMID: 15033975.
      Citations:    
    86. Tien ES, Gray JP, Peters JM, Vanden Heuvel JP. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes. Cancer Res. 2003 Sep 15; 63(18):5767-80. PMID: 14522898.
      Citations:    
    87. Peters JM, Aoyama T, Burns AM, Gonzalez FJ. Bezafibrate is a dual ligand for PPARalpha and PPARbeta: studies using null mice. Biochim Biophys Acta. 2003 Jun 10; 1632(1-3):80-9. PMID: 12782154.
      Citations:    
    Peters's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (376)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _